[Decision-making issues in the clinical management of pericarditis. A statement of the Italian Association of Hospital Cardiologists (ANMCO)]

G Ital Cardiol (Rome). 2018 Apr;19(4):248-259. doi: 10.1714/2898.29221.
[Article in Italian]

Abstract

Acute pericarditis is not uncommon in clinical practice and may occur either as isolated disease or as a manifestation of another disease (known or still unknown). The etiology is varied and complex and a clinically-oriented approach to management is possible by identifying initial presentation features of high risk (risk of complications or specific disease: fever >38°C, subacute course without acute chest pain, large pericardial effusion, cardiac tamponade, and lack of response to empiric anti-inflammatory therapy), that suggest admission and additional diagnostic evaluation. In any case, a prompt anti-inflammatory therapy at full doses till remission is warranted to prevent complicated and prolonged courses. In this paper, we will try to clarify common doubts and outline evidence-based approaches to the diagnosis, therapy and follow-up of these patients.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Cardiac Tamponade / prevention & control
  • Cardiac Tamponade / therapy*
  • Cardiologists
  • Clinical Decision-Making*
  • Combined Modality Therapy
  • Disease Progression
  • Early Diagnosis
  • Evidence-Based Medicine
  • Female
  • Humans
  • Italy
  • Male
  • Pericardial Effusion / prevention & control
  • Pericardial Effusion / therapy*
  • Pericardiocentesis / methods
  • Pericarditis / diagnosis
  • Pericarditis / mortality
  • Pericarditis / therapy*
  • Practice Guidelines as Topic*
  • Prognosis
  • Risk Assessment
  • Severity of Illness Index
  • Societies, Medical
  • Survival Rate
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents